Skip to main content
Cancer Medicine logoLink to Cancer Medicine
. 2025 Jan 20;14(2):e70322. doi: 10.1002/cam4.70322

Correction to “Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy”

PMCID: PMC11744295  PMID: 39829392

Dang, X., Li, P., Shen, A., Lu, Y., Zhu, Z., Zhang, M., Qian, W., Liang, A., & Zhang, W. (2024). Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy. Cancer Medicine, 13(6), e6991. doi: 10.1002/cam4.6991.

In the author byline, the spelling of “Zeyu Zhu” has been corrected.

We apologize for this error.


Articles from Cancer Medicine are provided here courtesy of Wiley

RESOURCES